Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells

Neurodegenerative Diseases

Volumn 7, Issue 6, 2010, Pages 349-364

  Nord, Linda Csöregh ^a   Sundqvist, Johanna ^a   Andersson, Eva ^a   Fried, Gabriel ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

17 Oestradiol; Alzheimer's disease; BACE

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; ESTRADIOL; ESTROGEN; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BRAIN; CELLS, CULTURED; ESTRADIOL; ESTROGENS; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MEMBRANE PROTEINS; NEUROGLIA; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRESENILIN-1; RNA, MESSENGER; TUBULIN;

EID: 78149298225     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000282279     Document Type: Article

References (47)

1. Maccioni RB, Muñoz JP, Barbeito L: The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 2001;32:367-381.
2. Selkoe DJ: Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999;399:A23-A 31.
3. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
4. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
5. Hurn PD, Macrae IM: Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000;20:631-652.
6. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J: Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968.
7. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA: Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006;91:1802-1810.
8. Henderson VW: Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006;138:1031-1039.
9. Sherwin BB: Estrogen and cognitive aging in women. Neuroscience 2006;138:1021-1026.
10. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE: Estrogen regulates metabolism of Alzheimer amyloid-beta precursor protein. J Biol Chem 1994;269:13065-13068.
11. Manthey D, Heck S, Engert S, Behl C: Estrogen induces a rapid secretion of amyloid-beta precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem 2001;268:4285-4291.
12. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S: Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 1998;4:447-451.
13. Petanceska SS, Nagy V, Frail D, Gandy S: Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid-beta peptides in brain. Exp Gerontol 2000;35:1317-1325.
14. Zheng H, Xu H, Uljon SN, Gross R, Hardy K, Gaynor J, Lafrancois J, Simpkins J, Refolo LM, Petanceska S, Wang R, Duff K: Modulation of Aβ peptides by estrogen in mouse models. J Neurochem 2002;80:191-196.
15. Potter H, Dressler D: The potential of BACE inhibitors for Alzheimer's therapy. Nat Biotechnol 2000;18:125-126.
16. Dewachter I, van Leuven F: Secretases as targets for the treatment of Alzheimer's disease: the prospects. Lancet Neurol 2002;1:409-416.
17. Hooper NM, Turner AJ: The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer's disease. Curr Med Chem 2002;9:1107-1119.
18. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M: Betasecretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-741.
19. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA: Evidence that tumornecrosis-factor-alpha- converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 1998;273:27765-27767.
20. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F: Constitutive and regulated alphasecretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 1999;96:3922-3927.
21. Steiner H, Haass C: Intramembrane proteolysis by presenilins. Nat Rev Mol Cell Biol 2000;1:217-224.
22. Vetrivel KS, Thinakaran G: Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology 2006;66: S69-S73.
23. Liesi P, Fried G, Stewart RR: Neurons and glial cells of the embryonic human brain and spinal cord express multiple and distinct isoforms of laminin. J Neurosci Res 2001;64:144-167.
24. Fried G, Andersson E, Csöregh L, Enmark E, Gustafsson JA, Aanesen A, Osterlund C: Estrogen receptor-beta is expressed in human embryonic brain cells and is regulated by 17beta-estradiol. Eur J Neurosci 2004;20:2345-2354.
25. Csöregh L, Andersson E, Fried G: Transcriptional analysis of estrogen effects in human embryonic neurons and glial cells. Neuroendocrinology 2009;89:171-186.
26. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
27. Wang H, Stjernholm Y, Ekman G, Eriksson H, Sahlin L: Different regulation of oestrogen receptors-alpha and-beta in the human cervix at term pregnancy. Mol Hum Reprod 2001;7:293-300.
28. Wang T, Brown MJ: mRNA quantification by real-time TaqMan polymerase chain reaction: validation and comparison with RNase protection. Anal Biochem 1999;269:198-201.
29. VanGuilder HD, Vrana KE, Freeman WM: Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008;44:619-626.
30. Greenbaum D, Colangelo C, Williams K, Gerstein M: Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003;4:117.
31. Goodenough S, Schäfer M, Behl C: Estrogeninduced cell signalling in a cellular model of Alzheimer's disease. J Steroid Biochem Mol Biol 2003;84:301-305.
32. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R: Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA 2005;102:19198-19203.
33. Li Y, Zhou W, Tong Y, He G, Song W: Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription. FASEB J 2006;20:285-292.
34. Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK: Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J 2004;18:1034-1036.
35. Cao X, Südhof TC: A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001;293:115-120.
36. Bao J, Cao C, Zhang X, Jiang F, Nicosia SV, Bai W: Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol Cell Biol 2007;27:1321-1333.
37. Feingold KR, Galvin LA, Schambelan M, Sebastian A: Cecil's Essentials of Medicine. Philadelphia, WB Saunders, 1990.
38. Schlöndorff J, Becherer JD, Blobel CP: Intracellular maturation and localization of the tumour necrosis factor-alpha convertase (TACE). Biochem J 2000;347(pt 1):131-138.
39. Kinoshita A, Fukumoto H, Shah T, Whelan CM, Irizarry MC, Hyman BT: Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci 2003;116:3339-3346.
40. Bernstein HG, Bukowska A, Krell D, Bogerts B, Ansorge S, Lendeckel U: Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J Neurocytol 2003;32:153-160.
41. Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M, Altevogt DP: ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 2003;17:292-294.
42. Marcello E, Gardoni F, Mauceri D, Romorini S, Jeromin A, Epis R, Borroni B, Cattabeni F, Sala C, Padovani A, di Luca M: Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci 2007;27:1682-1691.
43. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, George-Hyslop PS, Cordell B, Fraser P, de Strooper B: Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J Cell Biol 1999;147:277-294.
44. 42. J Biol Chem 1999;274:18851-18856.
45. Ray WJ, Yao M, Mumm J, Schroeter EH, Saftig P, Wolfe M, Selkoe DJ, Kopan R, Goate AM: Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch. J Biol Chem 1999;274:36801-36807.
46. Nizzari M, Venezia V, Bianchini P, Caorsi V, Diaspro A, Repetto E, Thellung S, Corsaro A, Carlo P, Schettini G, Florio T, Russo C: Amyloid precursor protein and presenilin 1 interaction studied by FRET in human H4 cells. Ann NY Acad Sci 2007;1096:249-257.
47. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS: Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001;414:643-648.